Disease | cutaneous t cell lymphoma |
Comorbidity | C0026946|mycosis |
Sentences | 8 |
PubMedID- 24813299 | Most g-ctcl is cd4(+), with granulomatous mycosis fungoides representing the vast majority of cases. |
PubMedID- 25798408 | Repeat assay of previous nasal biopsy showed the same t-cell receptor gene rearrangement leading to the diagnosis of cutaneous t-cell lymphoma, consistent with mycosis fungoides (mf). |
PubMedID- 23525618 | Primary cutaneous t-cell lymphomas (ctcl) excluding mycosis fungoides (mf) were discussed in 2 sessions of the 2011 society for hematopathology/ european association of haematopathology workshop, los angeles, ca. |
PubMedID- 24136145 | Patients with stages ib to ivb histologically confirmed ctcl (including mycosis fungoides (mf) and sézary syndrome) were enrolled in the study. |
PubMedID- 25386249 | We treated six ctcl patients (five with mycosis fungoides; four in stage iib, one in ivb, and one with peripheral cutaneous t-cell lymphoma (ptcl), unspecified) with 2cda (pulses of 0.12 mg/kg/day/5 days).10,12–20 the patients failed standard therapies including glucocorticoids, retinoids, methotrexate, radiotherapy, and phototherapy. |
PubMedID- 24576263 | Pyoderma gangrenosum-like cd30+ cutaneous t-cell lymphoma in a patient with mycosis fungoides. |
PubMedID- 24666254 | However, a number of well-recognized and rare types of ctcl, including mycosis fungoides, can present in isolated fashion. |
PubMedID- 25175592 | Methods: we analysed the files of 11 ctcl patients with mycosis fungoides (n = 10) or sezary syndrome (n = 1), who were treated with oral alitretinoin alone or in combination with standard treatment based on individual off-label treatment decisions. |
Page: 1